URT Urteste S.A.

12.93USD52.00 PLN · GPW+13.04%Mkt Cap: 19.73M USDP/E: —

Urteste S.A. engages in the research and development of diagnostic tests for cancers in Poland. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus…

Key Statistics

Company
Market Cap19.73M USD
Enterprise Value19.58M USD
Revenue (TTM)689.14K USD
Gross Profit-58.17K USD
Net Income (TTM)-1.49M USD
Revenue/Share0.47 USD
Last Price12.93 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees37
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLURTST00010
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-34.53
EV/Revenue28.42
P/S28.63
P/B3.52
EPS (TTM)-0.64 USD
EPS (Forward)—
52W Range
5.96758% of range17.95
52W High17.95 USD
52W Low5.967 USD
Profitability
Gross Margin-1063.64%
Oper. Margin-125.00%
EBITDA Margin-82.29%
Profit Margin-27186.36%
ROE-23.99%
ROA-13.25%
ROIC-30.06%
ROCE-17.13%
Growth
Revenue Growth55.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.65M USD
CapEx (TTM)3.09M USD
FCF Margin-378.28%
FCF Yield-13.21%
Net Debt-146.18K USD
Net Debt/EBITDA0.26
Net Debt/FCF—
Balance Sheet
Debt/Equity0.12
Current Ratio2.15
Quick Ratio2.15
Book Value/Sh3.67 USD
Cash/Share0.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.53M
Float1.19M
Insiders69.59%
Institutions13.64%
Technical
SMA 5010.55 (+22.5%)
SMA 20011.29 (+14.5%)
Beta0.20
S&P 52W Chg12.00%
Avg Vol (30d)990
Avg Vol (10d)481
Technical Indicators
RSI (14)75.1
MACD0.7353
MACD Signal-0.1609
MACD Hist.+0.8963
BB Upper11.85 USD
BB Middle10.67 USD
BB Lower9.483 USD
BB Width22.21%
ATR (14)0.6163 USD
Vol Ratio (20d)11.15x

About Urteste (WSE: URT)

›

Urteste (WSE: URT) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 37 employees.

The shares were at 52.00 PLN on 19 November 2026, up 4.0% over 52 weeks. Its 52-week range is 24.00 PLN to 72.20 PLN: the price is 28.0% below the high and 116.7% above the low.

Its market capitalisation is 79.36M PLN.

Urteste reports return on equity of -24.0%, an operating margin of -125.0% and revenue up 55.7% year over year.

It holds more cash than debt, a net cash position of 588.00K PLN. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.